A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice.
about
HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signalingThe aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancersEnvironmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor CellsThe role of the aryl hydrocarbon receptor in normal and malignant B cell developmentNrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitisAn aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2Gene-environment interactions in male reproductive health: special reference to the aryl hydrocarbon receptor signaling pathwayDepletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancerCardiac myocyte-specific AHR activation phenocopies TCDD-induced toxicity in zebrafish.Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse.Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptorp53 modulates Hsp90 ATPase activity and regulates aryl hydrocarbon receptor signaling.Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptorsConstitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesionsCorrelation analysis of liver tumor-associated genes with liver regenerationA novel in vitro pancreatic carcinogenesis model.Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activityAryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice.Aryl hydrocarbon receptor ligands in cancer: friend and foe.Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferationOverexpression of Catalase Enhances Benzo(a)pyrene Detoxification in Endothelial Microsomes.Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular MortalityBiological and tumor-promoting effects of dioxin-like and non-dioxin-like polychlorinated biphenyls in mouse liver after single or combined treatmentThe aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.Genomic profiling in nuclear receptor-mediated toxicity.Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells.Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Indole-3-carbinol induces tumor cell death: function follows form.Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer.Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhRDioxins: diagnostic and prognostic challenges arising from complex mechanismsTiming is everything: consequences of transient and sustained AhR activity.
P2860
Q24319032-E33C51C7-57AF-4705-8C27-7E346DF27F05Q24683145-C56785A7-2ABD-4924-B114-242E6841707DQ26747621-C8F8355F-7801-40A9-AB8F-B0C058B91A69Q26859116-DCC52263-306F-4348-98F0-905EA86A5964Q28392304-270B4953-BB83-4003-8608-EACCD348F465Q28393127-A6441F6A-7503-4F24-9A6C-9586B6C82E88Q28394896-91DD87AB-7C00-4A99-AECA-7A21AAFD7632Q28539741-1694A5C5-4102-4DA5-8AE7-6AF3C6201DA9Q30609840-68935A19-EAF1-4E70-BA9F-C23CF9713237Q33369976-E5A48D6A-A21D-4E7B-87C5-F89A3E7B11DFQ33586399-D4E9560B-BAE5-4111-8258-04E46D6B7E27Q33804702-B55A7944-A1E8-458B-BEDA-CE94BD1F62A0Q33819326-EEF0AE1E-8B3B-4DC8-8F99-D7F346CAF754Q34048247-F6A0ADF0-9145-406F-8476-FB94956236ABQ34097422-F5787E88-9132-4F53-982D-C92F24A3A839Q34233029-C8B3901F-AB05-4BA3-922B-5BD2904AB2D7Q34641046-FC3ADCA2-1707-4B02-82A9-11A683251158Q34913785-A470FA96-4907-47E2-94F0-BBA0C60ED635Q34994927-0A31CAE4-A24E-4DD4-ABE7-AA9A47AED26FQ35120292-E338E77F-DCFF-476C-A04F-46654D0E4F3EQ35458027-C92202CA-1C69-4889-B2B6-7CCAA8A2FFB4Q35670922-E0C6BBC3-F149-4E50-A1A5-D2EF6C781352Q35913114-2CBC6CFB-A4C4-4F79-8F24-19C652E045D0Q35994001-7356DA49-893C-4FC4-A4B5-13E512753E9EQ36126689-750C9188-FD46-4F2C-B940-EAC8F4A9173DQ36456169-CB51B49E-0F81-47D5-8D98-B7A5E74DFF31Q36769378-72F59515-BE52-4F8D-8431-2831A604C8FEQ36782397-302DDD66-BF57-4F37-906D-E29AA083632EQ36846922-027E2D01-1288-4F98-AD84-25EC6E93CCE5Q36873039-90FFA3A2-C4A0-466C-B99E-51FFED49C9D7Q36940631-C6206F75-6710-4321-951E-A3E8D22DDD26Q37108803-B95EA827-FA01-4D08-8AE7-0E1D00C040D3Q37121662-2FB4AFE5-8CB6-4A8A-9431-3F28DA5416BAQ37135777-3A7D9E3B-2B06-41BD-95DB-084D43330BDDQ37157820-D188BA3A-5A37-4D9F-873C-C62EE2C8EB77Q37188766-5891034D-765B-46F4-B7AB-7A292F66D13FQ37231015-158230B5-5685-47A0-B940-F7FBF873A3EAQ37242203-BD6F237A-D92A-41D1-8491-0DEA2D7BF2D1Q37255560-FAA7D1A6-916E-4165-8075-1D3EE25DD75EQ37332752-04B335CF-4F76-4A5D-A387-E52153B6E3A1
P2860
A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@en
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@nl
type
label
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@en
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@nl
prefLabel
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@en
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@nl
P2093
P1433
P1476
A constitutively active dioxin ...... hepatocarcinogenesis in mice.
@en
P2093
Albrecht Buchmann
Carina Ittrich
Lorenz Poellinger
Michael Schwarz
Oliver Moennikes
Patrik Andersson
Sandra Loeppen
P304
P356
10.1158/0008-5472.CAN-03-0875
P407
P577
2004-07-01T00:00:00Z